MGO One Seven’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,495
| Closed | -$336K | – | 1605 |
|
|
2026
Q1 | $336K | Buy |
1,495
+418
| +39% | +$104K | 0.01% | 1078 |
|
|
2025
Q4 | $259K | Sell |
1,077
-49
| -4% | -$12.5K | 0.01% | 1177 |
|
|
2025
Q3 | $308K | Buy |
+1,126
| New | +$308K | 0.01% | 1020 |
|
|
2025
Q2 | – | Sell |
-1,420
| Closed | -$318K | – | 1255 |
|
|
2025
Q1 | $318K | Sell |
1,420
-1,140
| -45% | -$266K | 0.01% | 794 |
|
|
2024
Q4 | $585K | Buy |
2,560
+190
| +8% | +$45.7K | 0.02% | 581 |
|
|
2024
Q3 | $579K | Sell |
2,370
-1,667
| -41% | -$372K | 0.03% | 536 |
|
|
2024
Q2 | $773K | Buy |
4,037
+766
| +23% | +$155K | 0.04% | 438 |
|
|
2024
Q1 | $648K | Sell |
3,271
-407
| -11% | -$74.6K | 0.03% | 454 |
|
|
2023
Q4 | $633K | Buy |
3,678
+1,431
| +64% | +$220K | 0.04% | 447 |
|
|
2023
Q3 | $332K | Buy |
2,247
+9
| +0.4% | +$1.63K | 0.03% | 579 |
|
|
2023
Q2 | $489K | Sell |
2,238
-68
| -3% | -$15.2K | 0.04% | 422 |
|
|
2023
Q1 | $505K | Sell |
2,306
-56
| -2% | -$12.1K | 0.03% | 475 |
|
|
2022
Q4 | $492K | Sell |
2,362
-172
| -7% | -$37.8K | 0.05% | 393 |
|
|
2022
Q3 | $553 | Sell |
2,534
-153
| -6% | -$34.8K | 0.02% | 364 |
|
|
2022
Q2 | $563K | Sell |
2,687
-115
| -4% | -$24.5K | 0.08% | 294 |
|
|
2022
Q1 | $680K | Sell |
2,802
-163
| -5% | -$39.4K | 0.07% | 298 |
|
|
2021
Q4 | $772K | Buy |
2,965
+51
| +2% | +$13.2K | 0.08% | 270 |
|
|
2021
Q3 | $766K | Sell |
2,914
-142
| -5% | -$38.8K | 0.1% | 254 |
|
|
2021
Q2 | $753K | Sell |
3,056
-128
| -4% | -$26.9K | 0.11% | 240 |
|
|
2021
Q1 | $617K | Sell |
3,184
-42
| -1% | -$8.42K | 0.11% | 250 |
|
|
2020
Q4 | $686K | Sell |
3,226
-232
| -7% | -$46.3K | 0.14% | 192 |
|
|
2020
Q3 | $593K | Sell |
3,458
-149
| -4% | -$27.5K | 0.14% | 192 |
|
|
2020
Q2 | $693K | Sell |
3,607
-1,102
| -23% | -$180K | 0.18% | 151 |
|
|
2020
Q1 | $693K | Sell |
4,709
-276
| -6% | -$44K | 0.24% | 114 |
|
|
2019
Q4 | $772K | Sell |
4,985
-76
| -2% | -$11K | 0.2% | 134 |
|
|
2019
Q3 | $684K | Buy |
5,061
+134
| +3% | +$17.6K | 0.2% | 137 |
|
|
2019
Q2 | $601K | Sell |
4,927
-829
| -14% | -$91.8K | 0.19% | 153 |
|
|
2019
Q1 | $598K | Buy |
5,756
+2,579
| +81% | +$266K | 0.19% | 156 |
|
|
2018
Q4 | $361K | Sell |
3,177
-294
| -8% | -$31.5K | 0.15% | 151 |
|
|
2018
Q3 | $400K | Buy |
+3,471
| New | +$380K | 0.19% | 150 |
|
|
2018
Q1 | $414K | Sell |
4,206
-542
| -11% | -$51.2K | 0.19% | 125 |
|
|
2017
Q4 | $402K | Buy |
+4,748
| New | +$392K | 0.19% | 131 |
|
Other funds holding RMD
MGO One Seven's RMD Position: Q2 2026 in Review
MGO One Seven sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,495 shares — an estimated $336K sold.
MGO One Seven first reported a position in RMD in Q4 2017 and held it in 32 quarters. The position peaked at $773K in Q2 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- MGO One Seven reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
- MGO One Seven sold 1,495 ResMed shares in Q2 2026, an estimated $336K.
- MGO One Seven first reported a position in ResMed in Q4 2017 and held it in 32 quarters.
- MGO One Seven's ResMed position peaked at $773K in Q2 2024.
- 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.